Analyst Price Targets — ACH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 12, 2026 12:51 pm | — | UBS | $4.50 | $3.34 | TheFly | Accendra Health price target raised to $4.50 from $3 at UBS |
| May 12, 2026 10:26 am | — | Robert W. Baird | $6.00 | $3.89 | TheFly | Accendra Health price target raised to $6 from $5 at Baird |
| February 22, 2026 7:17 pm | Kevin Caliendo | UBS | $3.00 | $2.61 | TheFly | Accendra Health price target lowered to $3 from $4 at UBS |
| January 6, 2026 2:32 pm | Eric Coldwell | Robert W. Baird | $5.00 | $9.04 | TheFly | Accendra Health price target lowered to $5 from $7 at Baird |
| November 3, 2025 9:06 am | Kevin Caliendo | UBS | $4.00 | $3.97 | StreetInsider | UBS Downgrades Owens & Minor (OMI) to Neutral |
| August 13, 2025 9:40 am | Kevin Caliendo | UBS | $7.00 | $5.47 | TheFly | Owens & Minor price target lowered to $7 from $13 at UBS |
| August 11, 2025 7:11 am | Michael Minchak | J.P. Morgan | $10.00 | $7.09 | Benzinga | Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings |
| August 8, 2025 8:56 am | Eric Coldwell | Robert W. Baird | $10.00 | $7.09 | TheFly | Owens & Minor upgraded to Outperform from Neutral at Baird |
| November 5, 2024 11:51 am | Eric Coldwell | Robert W. Baird | $14.00 | $11.80 | StreetInsider | Owens & Minor (OMI) PT Lowered to $14 at Baird |
| September 23, 2024 6:53 am | Eric Coldwell | Robert W. Baird | $19.00 | $16.08 | StreetInsider | Baird Reiterates Neutral Rating on Owens & Minor (OMI) |
Latest News for ACH
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) today announced the expiration and final results of the previously announced offers to exchange (the âE
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). As of 5:00 P.M.,…
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) today announced the early results of the previously announced offers to exchange (the âExchange Offersâ
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACH.
U.S. House Trading
No House trades found for ACH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.